Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study

OBJECTIVES: To estimate the costs and healthcare resources of patients with diabetic macular oedema (DME) who received intravitreal antivascular endothelial growth factor (anti-VEGF) agents or a dexamethasone intravitreal implant (DEX-implant) in Korea. DESIGN: Retrospective cohort study. SETTING: T...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open
Glavni autori: Cho, HyunJeong, Choi, Kyung Seek, Lee, Joo Yong, Lee, Donghwan, Choi, Nam-Kyong, Lee, YouKyung, Bae, SeungJin
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2019
Teme:
Public Health
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756349/
https://ncbi.nlm.nih.gov/pubmed/31542758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-030930
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items